As it appeared a merger between Atrium Health Floyd and the Harbin Clinic was near finalization, the Federal Trade Commission stepped in to take a closer look at the proposal.
An internal Harbin Clinic email obtained by the Rome News-Tribune this week states that the FTC is seeking a closer look at the merger plans — however, Harbin CEO Kenna Stock says the clinic and Atrium remain committed to the deal.
Industry insiders say that it’s possible the second look by the FTC could push the deal back by six months to as far as two and a half years.
While that long of a delay in and of itself could torpedo the deal, the review itself is not necessarily a death knell.
Both parties this week stated they remain firm in their resolve to see the deal through.
Comments